Lucid Diagnostics (LUCD) Change in Account Payables (2020 - 2026)
Lucid Diagnostics (LUCD) posted Change in Account Payables of $108000.0 for Q1 2026, down 50.91% on a QoQ basis from $220000.0 in Q4 2025, and up 126.21% year-over-year from $47742.5 in Q1 2025.
Lucid Diagnostics (LUCD) Change in Account Payables (2020 - 2026) Analysis & Trends
Lucid Diagnostics' Change in Account Payables history runs 7 years deep, the most recent figure standing at $108000.0 for Q1 2026.
- Quarterly Change in Account Payables rose 126.21% year-over-year to $108000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $250000.0 (up 278.57% YoY) and the FY2025 annual result came in at -$270000.0, down 381.25% from the prior year.
- Change in Account Payables was $108000.0 for Q1 2026 at Lucid Diagnostics, down from $220000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.0 million in Q1 2022 and bottomed at -$1.3 million in Q3 2022.
- A 5-year average of -$24823.5 and a median of $4000.0 in 2025 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2023 — Change in Account Payables soared 364.91% — and 2024, when it slumped 658.33%.
- Lucid Diagnostics' Change in Account Payables stood at -$57000.0 in 2022, then surged by 364.91% to $151000.0 in 2023, then decreased by 29.8% to $106000.0 in 2024, then jumped by 107.55% to $220000.0 in 2025, then tumbled by 50.91% to $108000.0 in 2026.
- Business Quant data shows LUCD's Change in Account Payables at $108000.0 in Q1 2026, $220000.0 in Q4 2025, and -$82000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lucid Diagnostics | 133.09 Mn | 105.22 Mn | -325,000.00 | 108,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108,000.00 |
| Mar 31, 2026 | 108,000.00 |
| Dec 31, 2025 | 220,000.00 |
| Dec 31, 2025 | 220,000.00 |
| Sep 30, 2025 | -82,000.00 |
| Sep 30, 2025 | -82,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | -412,000.00 |
| Mar 31, 2025 | -412,000.00 |
| Dec 31, 2024 | 106,000.00 |
| Dec 31, 2024 | 106,000.00 |
| Sep 30, 2024 | 233,000.00 |
| Sep 30, 2024 | 233,000.00 |
| Jun 30, 2024 | -67,000.00 |
| Jun 30, 2024 | -67,000.00 |
| Mar 31, 2024 | -176,000.00 |
| Mar 31, 2024 | -176,000.00 |
| Dec 31, 2023 | 151,000.00 |
| Dec 31, 2023 | 151,000.00 |